This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Nutritional and Metabolic Disorders, Other  • Ophthalmology  • Ophthalmological Disorders  • Diabetic Retinopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group

JAMA. 2002;287:2563-2569.

The purpose of this report is to summarize and integrate the findings of the Diabetes Control and Complications Trial (DCCT), a randomized controlled clinical trial, and the succeeding observational follow-up of the DCCT cohort in the Epidemiology of Diabetes Interventions and Complications (EDIC) study, regarding the effects of intensive treatment on the microvascular complications of type 1 diabetes mellitus. The DCCT proved that intensive treatment reduced the risks of retinopathy, nephropathy, and neuropathy by 35% to 90% compared with conventional treatment. The absolute risks of retinopathy and nephropathy were proportional to the mean glycosylated hemoglobin (HbA_1c) level over the follow-up period preceding each event. Intensive treatment was most effective when begun early, before complications were detectable. These risk reductions, achieved at a median HbA_1c level difference of 9.1% for conventional treatment vs 7.3% for intensive treatment have been maintained through 7 years of EDIC, even though the difference in mean HbA_1c levels of the 2 former randomized treatment groups was only 0.4% at 1 year (P<.001) (8.3% in the former conventional treatment group vs 7.9% in the former intensive treatment group), continued to narrow, and became statistically nonsignificant by 5 years (8.1% vs 8.2%, P = .09). The further rate of progression of complications from their levels at the end of the DCCT remains less in the former intensive treatment group. Thus, the benefits of 6.5 years of intensive treatment extend well beyond the period of its most intensive implementation. Intensive treatment should be started as soon as is safely possible after the onset of type 1 diabetes mellitus and maintained thereafter, aiming for a practicable target HbA_1c level of 7.0% or less.

A complete list of the Diabetes Control and Complications Trial Research Group appears in N Engl J Med. 1993;329:977-986. A complete list of the Epidemiology of Diabetes Interventions and Complications Research Group appears in Diabetes Care. 1999;22:99-111.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

May 15, 2002
JAMA. 2002;287(19):2593-2994.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick et al.
Diabetes Care 2009;32:1901-1903.
ABSTRACT | FULL TEXT  

Long-Term Glycemic Control Influences the Long-Lasting Effect of Hyperglycemia on Endothelial Function in Type 1 Diabetes
Ceriello et al.
J. Clin. Endocrinol. Metab. 2009;94:2751-2756.
ABSTRACT | FULL TEXT  

The Transforming Growth Factor-{beta} Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy
Gerhardinger et al.
Diabetes 2009;58:1659-1667.
ABSTRACT | FULL TEXT  

Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)
Pop-Busui et al.
Circulation 2009;119:2886-2893.
ABSTRACT | FULL TEXT  

Progress in Diabetes Research--What's Next
Nathan
JAMA 2009;301:1599-1601.
FULL TEXT  

Metabolic Memory in Diabetes Is True Long-term Memory
Frank
Arch Ophthalmol 2009;127:330-331.
FULL TEXT  

The "Metabolic Memory": Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications?
Ceriello et al.
J. Clin. Endocrinol. Metab. 2009;94:410-415.
ABSTRACT | FULL TEXT  

Role of Glyceraldehyde 3-Phosphate Dehydrogenase in the Development and Progression of Diabetic Retinopathy
Kanwar and Kowluru
Diabetes 2009;58:227-234.
ABSTRACT | FULL TEXT  

Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 Dimethylation: An Epigenetic Study in Diabetes
Miao et al.
Diabetes 2008;57:3189-3198.
ABSTRACT | FULL TEXT  

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
Kilpatrick et al.
Diabetes Care 2008;31:2198-2202.
ABSTRACT | FULL TEXT  

The Relationship Between Oral Health and Diabetes Mellitus
Lamster et al.
Journal of the American Dental Association 2008;139:19S-24S.
ABSTRACT | FULL TEXT  

Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus
Kilpatrick
J. Clin. Pathol. 2008;61:977-982.
ABSTRACT | FULL TEXT  

Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
Weinzimer et al.
Diabetes Care 2008;31:934-939.
ABSTRACT | FULL TEXT  

Is Glycemic Control Improving in U.S. Adults?
Hoerger et al.
Diabetes Care 2008;31:81-86.
ABSTRACT | FULL TEXT  

Internet Diabetic Patient Management Using a Short Messaging Service Automatically Produced by a Knowledge Matrix System
Kim et al.
Diabetes Care 2007;30:2857-2858.
FULL TEXT  

Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial Completion: Possible predictors of incident neuropathy?
Albers et al.
Diabetes Care 2007;30:2613-2618.
ABSTRACT | FULL TEXT  

Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy
Dominguez et al.
Am. J. Physiol. Renal Physiol. 2007;293:F670-F679.
ABSTRACT | FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

Diabetes Epidemiology: Guiding Clinical and Public Health Practice: The Kelly West Award Lecture, 2006
Herman
Diabetes Care 2007;30:1912-1919.
FULL TEXT  

Randomized Study to Characterize Glycemic Control and Short-Term Pulmonary Function in Patients with Type 1 Diabetes Receiving Inhaled Human Insulin (Exubera)
Norwood et al.
J. Clin. Endocrinol. Metab. 2007;92:2211-2214.
ABSTRACT | FULL TEXT  

Is There a Place for Insulin Pump Therapy in Your Practice?
Skyler et al.
Clin. Diabetes 2007;25:50-56.
ABSTRACT | FULL TEXT  

Comorbidity in Older Adults: Nosology of Impairment, Diseases, and Conditions
Karlamangla et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007;62:296-300.
ABSTRACT | FULL TEXT  

Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes: "Double diabetes" in the Diabetes Control and Complications Trial
Kilpatrick et al.
Diabetes Care 2007;30:707-712.
ABSTRACT | FULL TEXT  

An Uncompromising Approach to Achieving Glycemic Goals
Gavin
The Diabetes Educator 2007;33:52S-59S.
FULL TEXT  

Assessing Glycemic Control With Self-monitoring of Blood Glucose and Hemoglobin A1c Measurements
Dailey
Mayo Clin Proc. 2007;82:229-236.
ABSTRACT | FULL TEXT  

Painful Diabetic Neuropathy: A Management-Centered Review
Huizinga and Peltier
Clin. Diabetes 2007;25:6-15.
ABSTRACT | FULL TEXT  

The Experiences of School Nurses Caring for Students Receiving Continuous Subcutaneous Insulin Infusion Therapy
Darby
The Journal of School Nursing 2006;22:336-344.
ABSTRACT | FULL TEXT  

Long-Term Effect of the Internet-Based Glucose Monitoring System on HbA1c Reduction and Glucose Stability: A 30-month follow-up study for diabetes management with a ubiquitous medical care system
Cho et al.
Diabetes Care 2006;29:2625-2631.
ABSTRACT | FULL TEXT  

Validation of a Novel Point-of-Care Nerve Conduction Device for the Detection of Diabetic Sensorimotor Polyneuropathy.
Perkins et al.
Diabetes Care 2006;29:2023-2027.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease
Antonetti et al.
Diabetes 2006;55:2401-2411.
ABSTRACT | FULL TEXT  

Diabetes as a Tracer Condition in International Benchmarking of Health Systems
Nolte et al.
Diabetes Care 2006;29:1007-1011.
ABSTRACT | FULL TEXT  

Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c
Saudek et al.
JAMA 2006;295:1688-1697.
ABSTRACT | FULL TEXT  

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion
Martin et al.
Diabetes Care 2006;29:340-344.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus
Shea et al.
J. Am. Med. Inform. Assoc. 2006;13:40-51.
ABSTRACT | FULL TEXT  

Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes
Genuth et al.
Diabetes 2005;54:3103-3111.
ABSTRACT | FULL TEXT  

Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized, Controlled Trial
Rosenstock et al.
ANN INTERN MED 2005;143:549-558.
ABSTRACT | FULL TEXT  

Effect of Ruboxistaurin on Blood-Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema
Strom et al.
IOVS 2005;46:3855-3858.
ABSTRACT | FULL TEXT  

Case Study: Whose Diabetes Is It Anyway? Diabetes Self-Management After a Stroke
Martin
Diabetes Spectr. 2005;18:196-198.
FULL TEXT  

The Scope of Practice, Standards of Practice, and Standards of Professional Performance for Diabetes Educators
The Diabetes Educator 2005;31:487-512.
FULL TEXT  

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial
Skyler et al.
Diabetes Care 2005;28:1630-1635.
ABSTRACT | FULL TEXT  

Basal Insulin Therapy in Type 2 Diabetes
Bethel and Feinglos
J Am Board Fam Med 2005;18:199-204.
ABSTRACT | FULL TEXT  

A Real-World Approach to Insulin Therapy in Primary Care Practice
Hirsch et al.
Clin. Diabetes 2005;23:78-86.
FULL TEXT  

Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Steffes et al.
Clin. Chem. 2005;51:753-758.
ABSTRACT | FULL TEXT  

Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association
Silverstein et al.
Diabetes Care 2005;28:186-212.
FULL TEXT  

Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications
Obrosova et al.
Diabetes 2005;54:234-242.
ABSTRACT | FULL TEXT  

The Vermont Diabetes Information System (VDIS): study design and subject recruitment for a cluster randomized trial of a decision support system in a regional sample of primary care practices
MacLean et al.
Clin Trials 2004;1:532-544.
ABSTRACT  

A Prospective Study of Serum Lipids and Risk of Diabetic Macular Edema in Type 1 Diabetes
Miljanovic et al.
Diabetes 2004;53:2883-2892.
ABSTRACT | FULL TEXT  

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy
Polydefkis et al.
Brain 2004;127:1606-1615.
ABSTRACT | FULL TEXT  

Implementation of Guidelines for the Prevention of Diabetic Nephropathy
Fagerudd et al.
Diabetes Care 2004;27:803-804.
FULL TEXT  

Overview
Chew
Br J Ophthalmol 2004;88:436-437.
FULL TEXT  

Three-Year Follow-up Study of Blood-Retinal Barrier and Retinal Thickness Alterations in Patients With Type 2 Diabetes Mellitus and Mild Nonproliferative Diabetic Retinopathy
Lobo et al.
Arch Ophthalmol 2004;122:211-217.
ABSTRACT | FULL TEXT  

Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah et al.
JAMA 2004;291:335-342.
ABSTRACT | FULL TEXT  

It Takes a Village: Helping Families Live With Diabetes
Butler and Lawlor
Diabetes Spectr. 2004;17:26-31.
ABSTRACT | FULL TEXT  

Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
Writing Team for the Diabetes Control and Complica
JAMA 2003;290:2159-2167.
ABSTRACT | FULL TEXT  

Low-Glycemic Index Diets in the Management of Diabetes: A meta-analysis of randomized controlled trials
Brand-Miller et al.
Diabetes Care 2003;26:2261-2267.
ABSTRACT | FULL TEXT  

Type 2 and other forms of diabetes in 0-30 year olds: a hospital based study in Leeds, UK
Feltbower et al.
Arch. Dis. Child. 2003;88:676-679.
ABSTRACT | FULL TEXT  

Regression of Microalbuminuria in Type 1 Diabetes
Perkins et al.
NEJM 2003;348:2285-2293.
ABSTRACT | FULL TEXT  

Social Inequality in Childhood Diabetes--A Population-Based Follow-up Study in Germany
Icks et al.
Pediatrics 2003;111:222-224.
FULL TEXT  

Psychological Impact of Changing the Scale of Reported HbA1c Results Affects Metabolic Control
Hanas
Diabetes Care 2002;25:2110-2111.
FULL TEXT  

Predictors of Ketoacidosis and Severe Hypoglycemia in Type I Diabetes
Foster and Bratton
AAP Grand Rounds 2002;8:3-4.
FULL TEXT  

Avoiding High-Risk Behaviors: Smoking Prevention and Cessation in Diabetes Care
Tibbs and Haire-Joshu
Diabetes Spectr. 2002;15:164-169.
ABSTRACT | FULL TEXT  

Progress and Promise of Diabetes Research
Saudek
JAMA 2002;287:2582-2584.
FULL TEXT